Single-Use Bioprocessing Market: Current Analysis and Forecast (2021 - 2027)
- UnivDatos Market Insight
- July 2021
- 134 pages
Single-use systems are biopharmaceutical production (bioprocessing) products that are only used once and then discarded. Single-use systems are often made up of plastic components that have been disinfected and sealed using gamma irradiation.
The increasing popularity of disposables in biopharmaceutical manufacturing, rising instances of chronic diseases leading to the need for biological treatment, affordable disposable products and instruments, and developing life science research infrastructure drive the global single-use growth bioprocessing systems market. Moreover, advancements in the technology of bioprocessing systems also fuelled the global single-use bioprocessing systems market. Growing numbers of joint ventures and acquisitions and quick launches of new products are the significant trends of this global single-use bioprocessing systems market.
However, extractability problems about disposing of plastic bags and possible environmental harm are the factors that are restricting the growth of the single-use bioprocessing market. Moreover, the waste disposal of single-use processes is also a significant challenge faced by the market.
Based on product, the market is fragmented into media bags and containers, filtration assemblies, single-use bioreactors, disposable Mixers, and others. The media bags and containers segment generated revenue of USD XX billion in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX billion by 2027F owing to the growing adoption of media bags and containers in transportation and storage.
Based on the end-user, the market is fragmented into life science R&D
and biopharmaceutical manufacturers. The biopharmaceutical manufacturers
segment generated revenue of USD XX billion in 2020 and is anticipated to
reach USD XX billion by the year 2027F on account of the growing popularity
of disposables amongst contract manufacturers, growing at a CAGR of XX%
over the forecast period (2021-2027).
Based on the application, the market is fragmented into filtration, storage, cell culture, mixing, and purification. The filtration segment generated revenue of USD XX million in 2020 and is anticipated to reach USD XX million by the year 2027F, growing at a CAGR of XX% over the forecast period (2021-2027) on account of growing usage of single-use tangential flow filters, depth filters, and chromatography columns in process development can be ascribed to this substantial percentage.
For a better understanding of the market adoption of the Single-Use Bioprocessing market, the market is analyzed based on its worldwide penetration in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the Single-Use Bioprocessing industry and generated revenue of USD XX million in 2020 owing to the high R&D expenditure, the presence of largescale manufacturing units, the growing popularity of disposables, increasing healthcare expenditure, and the presence of well-established healthcare infrastructure.
Some of the major players operating in the market include Thermo Fisher
Scientific, Inc., Merck KGaA, Sartorius AG, Corning Incorporated, Pall
Corporation, General Electric Company (GE Healthcare), Eppendorf AG,
Rentschler Biopharma SE, Lonza, and Meissner Filtration Products, Inc, etc.
Several M&A’s along with partnerships have been undertaken by these
players to boost their presence in different regions.
Global Single-Use Bioprocessing Market was valued at USD XX million in 2020 and is projected to expand significantly with a CAGR of XX% from 2021-2027F. The global Single-Use Bioprocessing Market is expected to witness a boost on account of increasing demand for biopharmaceuticals, high energy efficiency, and emerging new players offering attractive products & services worldwide.
Single-use systems are biopharmaceutical production (bioprocessing) products that are only used once and then discarded. Single-use systems are often made up of plastic components that have been disinfected and sealed using gamma irradiation. The prevalence of chronic diseases has been continuously increasing worldwide. They are the world's leading killers, accounting for more than 63% of all deaths. If nothing is done to reverse this trend, the number of people dying from chronic diseases will increase by 17% in the following ten years. This has led to expanding clinical research activities to decipher the potential of biotherapeutics against various disease areas is expected to have a positive influence on the market for single-use bioprocessing.
Single-use bioprocessing in biopharmaceutical firms is expected to see healthy expansion in the future because of its numerous advantages over traditional bioprocessing technologies. These technologies have several advantages, including lower initial investment and R&D costs, lower labor and material costs, and the ability to be readily disposed of. Furthermore, as compared to stainless steel reactors used in conventional bioprocessing, these single-use bioprocessing units have a 35% better CO2 balance, which is why they are widely used by the manufacturer. Merck KGaA announced an extra EUR 40 million investment in Asia in 2018 for two years to establish a solid manufacturing and distribution network.
Furthermore, the increasing approval of drugs and other biologics has increased the demand for single-use disposables such as media bags and containers. The Center for Drug Evaluation and Research (CDER) approved 53 new medications in 2020. (CDER). Each year, the number of new medicinal items approved by the FDA fluctuates greatly: in 2016, just over 20 new pharmaceuticals were approved, while in 2018, almost 60 new products were approved. In the year 2020, 53 new medicines were approved. In 2019, many new pharmaceuticals will be developed, notably in the pharmaceutical business in the United States. Under the United States alone, nearly 1,100 novel drugs were in development for cancer and cancer-related illnesses as of April 2019. Hundreds of innovative treatments for uncommon ailments, neurological disorders, and skin diseases were also in the works.
Thermo Fisher Scientific, Inc., Merck KGaA, Sartorius AG, Corning Incorporated, Pall Corporation, General Electric Company (GE Healthcare), Eppendorf AG, Rentschler Biopharma SE, Lonza, and Meissner Filtration Products, Inc are some of the prominent players operating in the global Single-Use Bioprocessing market. Several M&A’s along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products.
Insights Presented in the Report
“Amongst Product Type, Media Bags and Containers segment holds the major share”
Based on the product type, the market is fragmented into media bags and containers, filtration assemblies, single-use bioreactors, disposable mixers, and others. The media bags and containers segment dominated the market with a share of XX% in 2020 and is expected to maintain its dominance during the forecast period owing to the growing adoption of media bags and containers in transportation and storage.
Amongst Applications, Filtration segment holds the major share”
Based on the application, the market is fragmented into filtration storage, cell culture, mixing, and purification. The filtration segment dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period. Furthermore, the segment is also expected to grow at the highest CAGR during the period.
“Amongst End-User, biopharmaceutical manufacturers segment dominated the market”
Based on end-user, the market is fragmented into life science R&D and biopharmaceutical manufacturers. In 2020, biopharmaceutical manufacturers accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period.
“North America signifies one of the largest markets of Single-Use Bioprocessing Market”
For a better understanding of the market dynamics of the Single-Use Bioprocessing market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 owing to the increased prevalence of chronic diseases and outbreak of COVID-19. The North American government has been investing heavily in the development of COVID-19 vaccines, treatments, and diagnostic tests, which is expected to increase demand for single-use bioreactors and, as a result, overall market growth.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts
- The report presents a quick review of overall industry performance at one glance
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
- The study comprehensively covers the market across different segments
- Deep dive regional level analysis of the industry
The Single-Use Bioprocessing Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Sartorius AG
- Corning Incorporated
- Pall Corporation
- General Electric Company (GE Healthcare)
- Eppendorf AG
- Rentschler Biopharma SE
- Meissner Filtration Products Inc
Have query on this report?Make an Enquiry
Table of Content
1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Single-Use Bioprocessing Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Single-Use Bioprocessing Market
2.1.1 Main Objective of the Global Single-Use Bioprocessing Market
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 TOP START-UPs UNDER SINGLE-USE BIOPROCESSING INDUSTRY
6 COVID-19 IMPACT
7 GLOBAL SINGLE-USE BIOPROCESSING MARKET REVENUE
8 MARKET INSIGHTS BY PRODUCT
8.1 Media bags and containers
8.2 Quick launches of new product
8.3 Single-use bioreactors
8.4 Disposable mixers
9 MARKET INSIGHTS BY END-USER
9.1 Life Science R&D
9.2 Biopharmaceutical Manufacturers
10 MARKET INSIGHTS BY APPLICATION
10.3 Cell Culture
11 MARKET INSIGHTS BY REGION
11.1 NORTH AMERICA SINGLE-USE BIOPROCESSING MARKET
11.1.1 United States
11.1.3 Rest of North America
11.2 EUROPE SINGLE-USE BIOPROCESSING MARKET
11.2.3 United Kingdom
11.2.6 Rest of Europe
11.3 ASIA PACIFIC SINGLE-USE BIOPROCESSING MARKET
11.3.5 South Korea
11.3.6 Rest of Asia Pacific
11.4 REST OF THE WORLD SINGLE-USE BIOPROCESSING MARKET
12 BABY MONITOR MARKET DYNAMICS
12.1 Market Drivers
12.2 Market Challenges
12.3 Impact Analysis
13 LEGAL & REGULATORY FRAMEWORK
14 DEMAND AND SUPPLY SIDE ANALYSIS
14.1 Demand Side Analysis
14.2 Supply Side Analysis
14.2.1 Top Product Launches
14.2.2 Top Business Partnerships
14.2.3 Top Merger & Acquisitions
15 VALUE CHAIN ANALYSIS
16 SINGLE-USE BIOPROCESSING MARKET OPPORTUNITIES
17 RSINGLE-USE BIOPROCESSING MARKET TRENDS & INSIGHTS
18 COMPETITIVE SCENARIO
18.1 Porter’s Five forces analysis
18.1.1 Bargaining power of Supplier
18.1.2 Bargaining power of Buyer
18.1.3 Industry Rivalry
18.1.4 Availability of Substitute
18.1.5 Threat of new Entrants
19 COMPANY PROFILED
19.1 Thermo Fisher Scientific, Inc.
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Key Product/Services Offerings
19.1.4 Growth Strategy
19.1.5 SWOT Analysis
19.1.6 Key Financials
19.1.7 Recent Developments
19.2 Merck KGA
19.3 Sartorius AG
19.4 Corning Incorporated
19.5 Pall Corporation
19.6 General Electric Company (GE Healthcare)
19.7 Eppendorf AG
19.8 Rentschler Biopharma SE
19.10 Meissner Filtration Products, Inc
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017